These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 9829329)

  • 1. Compared effects of sotalol, flecainide and propafenone on ventricular repolarization in patients free of underlying structural heart disease.
    Sarubbi B; Ducceschi V; Briglia N; Mayer MS; Santangelo L; Iacono A
    Int J Cardiol; 1998 Sep; 66(2):157-64. PubMed ID: 9829329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Sotalol, propafenone, and flecainide: compared multiparametric analysis of ventricular repolarization in subjects without organic cardiopathy].
    Sarubbi B; Ducceschi V; Briglia N; Esposito R; Mayer MS; Scialdone A; Santangelo L; Iacono A
    Cardiologia; 1996 Jul; 41(7):645-51. PubMed ID: 8983831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
    Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
    J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Divergent effect of acute ventricular dilatation on the electrophysiologic characteristics of d,l-sotalol and flecainide in the isolated rabbit heart.
    Eckardt L; Haverkamp W; Göttker U; Madeja M; Johna R; Borggrefe M; Breithardt G
    J Cardiovasc Electrophysiol; 1998 Apr; 9(4):366-83. PubMed ID: 9581953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propafenone during acute myocardial ischemia in patients: a double-blind, randomized, placebo-controlled study.
    Faber TS; Zehender M; Krahnefeld O; Daisenberger K; Meinertz T; Just H
    J Am Coll Cardiol; 1997 Mar; 29(3):561-7. PubMed ID: 9060894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. QTc compared to JTc for monitoring drug-induced repolarization changes in the setting of ventricular pacing.
    Tsai SF; Houmsse M; Dakhil B; Augostini R; Hummel JD; Kalbfleisch SJ; Liu Z; Love C; Rhodes T; Tyler J; Weiss R; Hamam I; Winner M; Daoud EG
    Heart Rhythm; 2014 Mar; 11(3):485-91. PubMed ID: 24252288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.
    Naccarelli GV; Wolbrette DL; Khan M; Bhatta L; Hynes J; Samii S; Luck J
    Am J Cardiol; 2003 Mar; 91(6A):15D-26D. PubMed ID: 12670638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of QT interval prolongation following antiarrhythmic drug therapy on left ventricular function.
    Chouchoulis K; Chiladakis J; Koutsogiannis N; Davlouros P; Kaza M; Alexopoulos D
    Future Cardiol; 2017 Jan; 13(1):13-22. PubMed ID: 27990843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrial-selective antiarrhythmic actions of novel Ikur vs. Ikr, Iks, and IKAch class Ic drugs and beta blockers in pigs.
    Knobloch K; Brendel J; Rosenstein B; Bleich M; Busch AE; Wirth KJ
    Med Sci Monit; 2004 Jul; 10(7):BR221-8. PubMed ID: 15232496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Idiopathic premature ventricular complexes treatment: Comparison of flecainide, propafenone, and sotalol.
    Kojić D; Radunović A; Bukumirić Z; Rajsic S; Sušić M; Marić M; Žugić V; Jurčević R; Tomović M
    Clin Cardiol; 2023 Oct; 46(10):1220-1226. PubMed ID: 37533168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of epinephrine over P wave duration and ventricular repolarization in subjects without structural heart disease.
    Fuenmayor AJ; Luisangelli Gómez R; Solórzano MI
    Int J Cardiol; 2016 Feb; 204():142-6. PubMed ID: 26657609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arrhythmogenic activities of antiarrhythmic drugs in conscious hypokalemic dogs with atrioventricular block: comparison between quinidine, lidocaine, flecainide, propranolol and sotalol.
    Weissenburger J; Davy JM; Chézalviel F; Ertzbischoff O; Poirier JM; Engel F; Lainée P; Penin E; Motté G; Cheymol G
    J Pharmacol Exp Ther; 1991 Nov; 259(2):871-83. PubMed ID: 1941633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reverse use dependence of human ventricular repolarization by chronic oral sotalol in monophasic action potential recordings.
    Shimizu W; Kurita T; Suyama K; Aihara N; Kamakura S; Shimomura K
    Am J Cardiol; 1996 May; 77(11):1004-8. PubMed ID: 8644624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrocardiographic interactions between pinacidil, a potassium channel opener and class I antiarrhythmic agents in guinea-pig isolated perfused heart.
    Yang Q; Padrini R; Bova S; Piovan D; Magnolfi G
    Br J Pharmacol; 1995 Apr; 114(8):1745-9. PubMed ID: 7599944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of termination of reentrant atrial arrhythmias by class I and class III antiarrhythmic agents.
    Spinelli W; Hoffman BF
    Circ Res; 1989 Dec; 65(6):1565-79. PubMed ID: 2510953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New antiarrhythmia agents: propafenone and flecainide].
    Leclercq JF
    Presse Med; 1985 Mar; 14(12):685-9. PubMed ID: 3157964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of sotalol on ventricular repolarization during exercise.
    Li J; Wang JA
    J Zhejiang Univ Sci B; 2005 Apr; 6(4):249-53. PubMed ID: 15754421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous amiodarone homogeneously prolongs ventricular repolarization in patients with life-threatening ventricular tachyarrhythmia.
    Kotake Y; Kurita T; Akaiwa Y; Yasuoka R; Motoki K; Kobuke K; Iwanaga Y; Miyazaki S
    J Cardiol; 2015 Aug; 66(2):161-7. PubMed ID: 25468767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diverse electrophysiologic effects of propafenone and flecainide in canine Purkinje fibers: implications for antiarrhythmic drug classification.
    Zaza A; Malfatto G; Schwartz PJ
    J Pharmacol Exp Ther; 1994 Apr; 269(1):336-43. PubMed ID: 8169840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of classifying antiarrhythmic actions since the cardiac arrhythmia suppression trial.
    Vaughan Williams EM
    J Clin Pharmacol; 1991 Feb; 31(2):123-35. PubMed ID: 1901320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.